Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
This analysis points to fund families that consistently stood out in index fund history, helping you recognize dominant players over time.
25,021 articlesAbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Bitcoin’s bear market struggle is driving layoffs and automation in crypto firms even as banks and fintechs chase big...
MP Materials stands at the crossroads of national strategy and market demand for critical minerals. This guide outlin...
SpaceX blends rockets, satellites, and AI dreams. This piece examines whether could spacex eventually become the top ...
Major research firm reaffirmed its price target on Terawulf as the company inks a long-term lease with Anthropic and ...
Micron looks cheaper than its earnings prospects suggest, but a closer look reveals cyclicality, demand swings, and r...
Insider transactions can reveal confidence or caution. This guide digs into ultra clean insider sells, what they sign...
A trading halt and a sharp drop put Lucid in the spotlight, but the company pushed back on bankruptcy chatter. This g...
A high-profile insider sale by AeroVironment's CEO has investors asking what it means for the stock. This guide break...
The U.S. government has expanded direct stakes in select public firms, tying national security goals to market moves ...
NuScale Power faces a high-stakes decade as regulators, financiers, and utilities weigh SMR potential. This article l...
Stanley Martin Homes will acquire United Homes Group in an all-cash deal valued at $221 million, taking UHG private a...